GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (LSE:IMM) » Definitions » Net Policyholder Benefits/Claims

ImmuPharma (LSE:IMM) Net Policyholder Benefits/Claims


View and export this data going back to 2003. Start your Free Trial

What is ImmuPharma Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


ImmuPharma (LSE:IMM) Business Description

Industry
Traded in Other Exchanges
Address
One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus and a life-threatening autoimmune disease.